Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis

Table of Contents

• Executive Summary
• Industry analysis
• Industry definition
• Research highlights
• Top 10 companies landscape
• Market Value
• Market Forecast
• Market Segmentation - Product
• Market Segmentation - Geographic
• Five Forces Analysis
• Summary
• Buyer power
• Supplier power
• New entrants
• Substitutes
• Rivalry
• Top 10 Companies Landscape
• Revenue analysis
• Financial performance analysis
• Company Reports
• Amgen
• Genentech
• Gilead Sciences
• UCB
• Genzyme
• Biogen Idec
• CSL
• Celgene
• Cephalon
• Actelion
• Financial Analysis
• Amgen
• Genentech
• Gilead Sciences
• UCB
• Genzyme
• Biogen Idec
• CSL
• Celgene
• Cephalon
• Actelion
• Appendix

FIGURES

• Figure 1: Global biotechnology market, $ million, 2003 - 07
• Figure 2: Global biotechnology market forecast, $ million, 2007 - 12
• Figure 3: Global biotechnology market segmentation - product, % share, 2007
• Figure 4: Global biotechnology market segmentation - geography, % share, 2007
• Figure 5: Forces driving competition in the global biotechnology market
• Figure 6: Drivers of buyer power in the global biotechnology market
• Figure 7: Drivers of supplier power in the global biotechnology market
• Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market
• Figure 9: Factors influencing the threat of substitutes in the global biotechnology market
• Figure 10: Drivers of degree of rivalry in the global biotechnology market
• Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008
• Figure 12: Revenue growth of global top 10 biotechnology companies, 2006 - 08
• Figure 13: Operating performance analysis, FY2008
• Figure 14: Net profit analysis, FY2008

TABLES

• Table 1: Global biotechnology market, $ million, 2003 - 07
• Table 2: Global biotechnology market forecast, $ million, 2007 - 12
• Table 3: Global biotechnology market segmentation - product , % share, 2007
• Table 4: Global biotechnology market segmentation - geography, % share, 2007
• Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008
• Table 6: Revenue growth of global top 10 biotechnology companies, 2006 - 08
• Table 7: Key financials of global top 10 biotechnology companies, FY2008
• Table 8: Key industry specific ratios, FY2008
• Table 9: Amgen - Financial and operational highlights, 2004 - 08 ($ million)
• Table 10: Amgen - Key industry specific ratios, 2004 - 2008
• Table 11: Genentech - Financial and operational highlights, 2004 - 08 ($ million)
• Table 12: Genentech - Key industry specific ratios, 2004 - 08
• Table 13: Gilead Sciences - Financial and operational highlights, 2004 - 08 ($ million)
• Table 14: Gilead Sciences - Key industry specific ratios, 2004 - 08
• Table 19: UCB - Financial and operational highlights, 2004 - 08 ($ million)
• Table 20: UCB - Key industry specific ratios, 2004 - 08
• Table 15: Genzyme - Financial and operational highlights, 2004 - 08 ($ million)
• Table 16: Genzyme - Key industry specific ratios, 2004 - 08
• Table 17: Biogen Idec - Financial and operational highlights, 2004 - 08 ($ million)
• Table 18: Biogen Idec - Key industry specific ratios, 2004 - 08
• Table 21: CSL - Financial and operational highlights, 2004 - 08 ($ million)
• Table 22: CSL - Key industry specific ratios, 2004 - 08
• Table 23: Celgene - Financial and operational highlights, 2004 - 08 ($ million)
• Table 24: Celgene - Key industry specific ratios, 2004 - 08
• Table 25: Cephalon - Financial and operational highlights, 2004 - 2008 ($ million)
• Table 26: Cephalon - Key industry specific ratios, 2004 - 08
• Table 27: Actelion - Financial and operational highlights, 2004 - 08 ($ million)
• Table 28: Actelion - Key industry specific ratios, 2004 - 08